Scientists As Advocates

Scientists As Advocates I contend that Scott Veggeberg's report on the Boston meeting of the American Association for the Advancement of Science (The Scientist, March 22, 1993, page 1) misquotes me on two key points. He misses the essence of what I was trying to convey. The point I was attempting to make in my talk was that journalists covering scientific disputes should treat with skepticim scientists who adopt advocacy positions that are not directly related to their own research. I used

Written byChristopher Anderson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I contend that Scott Veggeberg's report on the Boston meeting of the American Association for the Advancement of Science (The Scientist, March 22, 1993, page 1) misquotes me on two key points. He misses the essence of what I was trying to convey.

The point I was attempting to make in my talk was that journalists covering scientific disputes should treat with skepticim scientists who adopt advocacy positions that are not directly related to their own research.

I used a tongue-in-cheek rhetorical device I called a "blacklist" to distinguish those scientists who, in my mind, fall into this category. In retrospect, I regret the use of that term.

In any case, I did not include University of California, Berkeley, chemist Bruce Ames on my "blacklist," as Veggeberg reports. Instead, I specifically stated that Ames was "spared" being on the list because of his restraint in going beyond his own research. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies